Alzamend Neuro, Inc. (ALZN)

USD 0.74

(-3.61%)

Annual Income Statements

(In USD)
Breakdown 2024 2023 2022 2021 2020 2019
Revenue - - - - - -
Cost of Revenue 50.74 Thousand 23.06 Thousand - - - -
Gross Profit -50.74 Thousand -23.06 Thousand - - - -
Operating Expenses 9.93 Million 14.87 Million 12.31 Million 4.95 Million 4.42 Million 5 Million
Selling, General and Administrative Expenses 3.48 Million 7.42 Million 7.11 Million 3.64 Million 3.35 Million 1.3 Million
Research and Development Expenses 6.45 Million 7.44 Million 5.2 Million 1.31 Million 1.06 Million 3.7 Million
Other Expenses - - - - - -
Cost and Expenses 9.93 Million 14.87 Million 12.31 Million 4.95 Million 4.42 Million 5 Million
Operating Income -9.93 Million -14.87 Million -12.31 Million -4.95 Million -4.42 Million -5 Million
Interest Expense 10.1 Thousand 7701.00 46.52 Thousand 158.8 Thousand - -
Income Tax Expense - -144.82 Thousand 42.52 Thousand 157.09 Thousand -13.92 Thousand -146.38 Thousand
Earnings before Tax -9.94 Million -14.87 Million -12.36 Million -5.04 Million -4.41 Million -4.86 Million
Net Income -9.94 Million -14.87 Million -12.4 Million -5.2 Million -4.39 Million -4.86 Million
Earnings Per Share Basic -14.72 -22.89 -20.92 -10.75 -9.26 -12.40
Earnings Per Share Diluted -14.70 -22.89 -20.88 -10.74 -9.25 -12.40
Weighted Average Shares Outstanding 676 Thousand 650 Thousand 593 Thousand 484 Thousand 475 Thousand 392 Thousand
Weighted Average Shares Outstanding (Diluted) 676.56 Thousand 650.12 Thousand 593.96 Thousand 484.33 Thousand 475.02 Thousand 392.28 Thousand
Gross Margin - - - - - -
EBIT Margin - - - - - -
Profit Margin - - - - - -
EBITDA -9.88 Million -14.84 Million -12.31 Million - - -
Earnings Before Tax Margin - - - - - -

Income Statement Charts